DE60307082D1 - PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE - Google Patents

PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE

Info

Publication number
DE60307082D1
DE60307082D1 DE60307082A DE60307082A DE60307082D1 DE 60307082 D1 DE60307082 D1 DE 60307082D1 DE 60307082 A DE60307082 A DE 60307082A DE 60307082 A DE60307082 A DE 60307082A DE 60307082 D1 DE60307082 D1 DE 60307082D1
Authority
DE
Germany
Prior art keywords
desmopressin
dispersible
pharmaceutical composition
mouth valve
mouth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60307082A
Other languages
German (de)
Other versions
DE60307082T2 (en
DE60307082T4 (en
Inventor
Anders Nilsson
Hans Lindner
Jorgen Wittendorff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0210397.6A external-priority patent/GB0210397D0/en
Application filed by Ferring BV filed Critical Ferring BV
Application granted granted Critical
Publication of DE60307082D1 publication Critical patent/DE60307082D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
DE60307082A 2002-05-07 2003-05-07 PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE Expired - Lifetime DE60307082D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0210397.6A GB0210397D0 (en) 2002-05-07 2002-05-07 Pharmaceutical formulations
PCT/IB2002/004036 WO2003094885A1 (en) 2002-05-07 2002-09-20 Sublingual pharmaceutical formulation of desmopressin
PCT/IB2003/002368 WO2003094886A2 (en) 2002-05-07 2003-05-07 Desmopressin in an orodispersible dosage form

Publications (1)

Publication Number Publication Date
DE60307082D1 true DE60307082D1 (en) 2006-09-07

Family

ID=29422105

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60307082A Expired - Lifetime DE60307082D1 (en) 2002-05-07 2003-05-07 PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE
DE2003607082 Expired - Lifetime DE60307082T4 (en) 2002-05-07 2003-05-07 PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2003607082 Expired - Lifetime DE60307082T4 (en) 2002-05-07 2003-05-07 PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE

Country Status (10)

Country Link
JP (1) JP2006502972A (en)
AU (1) AU2003233118B8 (en)
BR (1) BR0309819A (en)
CA (1) CA2484724C (en)
DE (2) DE60307082D1 (en)
HR (1) HRP20041152B1 (en)
NO (1) NO335167B1 (en)
NZ (1) NZ535861A (en)
PT (1) PT1501534E (en)
WO (1) WO2003094886A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
JP4523265B2 (en) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 Orally disintegrating preparations for the treatment of urination disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
US7022340B2 (en) 2003-07-25 2006-04-04 Ferring B.V. Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP2322195A2 (en) * 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
ES2260563T3 (en) * 2003-11-13 2006-11-01 Ferring B.V. BLISTER PACKAGE AND SOLID PHARMACEUTICAL FORM FOR IT.
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
SI1550439T1 (en) * 2003-12-29 2006-08-31 Ferring Bv Method for preparing a solid dosage form of desmopressin
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
GB0406048D0 (en) * 2004-03-18 2004-04-21 Ardana Bioscience Ltd Drug formulations
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
WO2007098945A2 (en) * 2006-03-02 2007-09-07 Ferring International Center S.A. Stable solid dosage form comprising desmopressin
SE528446C2 (en) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Pharmaceutical composition comprising desmopressin, silica and starch
WO2009015037A2 (en) 2007-07-21 2009-01-29 Albany Molecular Research, Inc. 5-pyridinone substituted indazoles
RU2472539C2 (en) * 2007-08-06 2013-01-20 Аллерган, Инк. Methods and devices for desmopressin preparation delivery
EP2628727A3 (en) 2007-11-21 2013-12-25 Decode Genetics EHF Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
AU2009204048B2 (en) 2008-01-11 2013-08-01 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as MCH antagonists
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
PT3085381T (en) * 2008-05-21 2018-05-18 Ferring Bv Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
RU2506266C2 (en) 2009-01-26 2014-02-10 Израэл Инститьют Фо Байолоджикал Рисерч Bicyclic heterocyclic spirocompounds
TWI468157B (en) * 2009-04-29 2015-01-11 Intervet Int Bv Process to form a tablet, system for performing this process and package comprising the tablet
TWI471127B (en) 2009-04-29 2015-02-01 Intervet Int Bv A process for preparing an orally disintegrating tablet for human use, an orally disintegrating tablet thus obtained and a package containing the orally disintegrating tablet
KR101792696B1 (en) 2009-06-18 2017-11-02 알레간 인코포레이티드 Safe desmopressin administration
KR20120104512A (en) 2009-07-14 2012-09-21 알바니 몰레큘라 리써치, 인크. 5-ht3 receptor modulators, methods of making, and use thereof
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
AU2011234637B2 (en) * 2010-03-29 2013-08-29 Ferring B.V. A fast dissolving pharmaceutical composition
JO3112B1 (en) 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
AR083361A1 (en) * 2010-10-08 2013-02-21 Scherer Technologies Inc R P FAST DOSAGE FORM ORAL VACCINE DISSOLUTION USING ALMIDON
JP2011116764A (en) * 2011-02-08 2011-06-16 Fine Seymour H Medical composition containing low dose desmopressin
CA2848785A1 (en) 2011-09-16 2013-03-21 Ferring B.V. A fast dissolving pharmaceutical composition
JP5928159B2 (en) * 2012-05-28 2016-06-01 ニプロ株式会社 Pharmaceutical composition
TW201422254A (en) * 2012-11-21 2014-06-16 Ferring Bv Composition for immediate and extended release
CN103993061B (en) * 2014-05-20 2018-03-23 海南美合泰生物科技有限公司 A kind of production method of Isin glue collagen
KR20150144209A (en) * 2014-06-16 2015-12-24 훼링 비.브이. Pharmaceutical composition comprising stabilized desmopressin or pharmaceutically acceptable salt thereof
JP6341777B2 (en) * 2014-06-30 2018-06-13 リプリーズ バイオファーマシューティクス，エルエルシー Pharmaceutical composition containing low dose desmopressin
CA3046725A1 (en) 2017-01-11 2018-07-19 Ferring B.V. A fast disintegrating pharmaceutical composition
DE102017104472A1 (en) * 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Orodispersible tablet containing burlulipase and pharmaceutical composition prepared therefrom
JP2021518413A (en) 2018-03-20 2021-08-02 アイカーン スクール オブ メディシン アット マウント サイナイ Kinase inhibitor compounds and compositions and usage
EP3906233B1 (en) 2018-12-31 2024-01-31 Icahn School of Medicine at Mount Sinai Kinase inhibitor compounds and compositions and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
JP3253127B2 (en) * 1991-06-07 2002-02-04 帝國製薬株式会社 Preparation containing bioactive polypeptide
AU653026B2 (en) * 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
EP1146800A1 (en) * 1999-01-27 2001-10-24 Spenco Medical Corporation Therapeutic magnetic insoles
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions

Also Published As

Publication number Publication date
HRP20041152A2 (en) 2005-04-30
JP2006502972A (en) 2006-01-26
CA2484724C (en) 2007-01-16
PT1501534E (en) 2006-09-29
DE60307082T2 (en) 2007-01-18
WO2003094886A3 (en) 2004-07-22
NZ535861A (en) 2006-11-30
BR0309819A (en) 2005-03-01
CA2484724A1 (en) 2003-11-20
WO2003094886A2 (en) 2003-11-20
NO20045345L (en) 2005-02-07
AU2003233118B2 (en) 2006-10-26
DE60307082T4 (en) 2015-04-30
AU2003233118B8 (en) 2009-07-30
NO335167B1 (en) 2014-10-06
AU2003233118A1 (en) 2003-11-11
HRP20041152B1 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
DE60307082D1 (en) PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE
DE60304993D1 (en) DISPERSIBLE PHARMACEUTICAL COMPOSITION WITH AGOMELATIN IN THE MOUTH VALVE
PT1919894E (en) Novel polyquinoline derivatives and the therapeutic use thereof
DK1501534T3 (en) Desmopressin in orodispersible dosage form
IL207953A0 (en) Gastrin - releasing peptide compounds and methods utilizing the same
IL187317A0 (en) A polypeptide complex and pharmaceutical compositions containing the same
IL179300A0 (en) Novel-antigen-binding polypeptides and their uses
IL182947A0 (en) Chimeric polypeptides and pharmaceutical compositions containing the same
DE502006005914D1 (en) SEN IN THE BODY'S INSIDE
EP1824467A4 (en) Apogossypolone and the uses thereof
EP1723408A4 (en) Nanowire light sensor and kit with the same
GB2396016B (en) J-spectroscopy in the wellbore
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
IS7140A (en) Improvement with or in connection with the coating
PL375568A1 (en) Floor-furnace chimney and the use thereof
HK1075272A1 (en) Dye composition and the use thereof
HK1073664A1 (en) Dye compositions and the use thereof
DE60305642D1 (en) DISPERSIBLE PHARMACEUTICAL COMPOSITION WITH PIRIBEDIL IN THE MOUTH VALVE
GB0312340D0 (en) Improved game and aricle for use with the game
GB0323138D0 (en) Pyrimidines substituted in the 2,4,6 positions and their different uses
ITRM20040242A1 (en) "7-T-BUTOSSIIMMINOMETILCAMPTOTECINA CONJUGED IN POSITION 20 WITH INTEGRINE ANTAGONISTS.
FR2863010B1 (en) ADAPTABLE STOPPER AND HEAD SEAL EQUIPPED WITH THE SAID STOPPER
ITTO20060204A1 (en) COLLECTORS, IN PARTICULAR, STACKABLE AND INSERTABLE THE ONE INSIDE THE OTHER
FI20045309A (en) Method and arrangement in the coating line
HK1082770A1 (en) Supter-antigen fusion proteins and the use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition